Xd. Zhou et al., RECURRENCE AFTER RESECTION OF ALPHA-FETOPROTEIN-POSITIVE HEPATOCELLULAR-CARCINOMA, Journal of cancer research and clinical oncology, 120(6), 1994, pp. 369-373
The long-term prognosis of surgery for hepatocellular carcinoma (HCC)
is not yet satisfactory, the main reason being the high recurrence rat
e. The authors report the results of a long-term follow-up of 308 pati
ents with HCC who became alpha-fetoprotein-(AFP)-negative after resect
ion between 1975 and 1991. By March 1992, there was recurrence in 134
patients (43.5%). The 1-, 3-, 5- and 10-year recurrence rates were 9.2
%, 38.8%, 54.9% and 85.0%, respectively. The 5-year survival rate was
49.7% for patients who had undergone a second hepatic resection (n = 4
8). Analysis of factors influencing postoperative recurrence indicated
that patients subjected to mass survey, with a lower gamma-glutamyltr
ansferase level, at an early stage of TNM classification, with a tumou
r of less than 5 cm, without tumour embolus, and with postoperative im
munotherapy had a lower incidence of recurrence. It is concluded that
the earlier the disease is diagnosed, the less the recurrence rate; ad
juvant immunotherapy may reduce postoperative recurrence, and the earl
y detection and resection of a recurrent tumour are important to prolo
nging survival further after curative resection of HCC.